Quantitation of Polydeoxyribonucletides (PDRNs) in Human Placental Extract by Fluorescence Spectroscopy Using Ethidium Bromide

DOI: 10.4236/ajac.2014.512087   PDF   HTML     3,844 Downloads   4,946 Views   Citations


Characterization of an aqueous extract of human placenta, used as a licensed drug for wound healing, leads to the identification of several bioactive components including polydeoxyribonu-cleotides (PDRNs). PDRNs are mixture of DNA fragments of different molecular weight. A spectro-fluorimetric method of quantitation of PDRNs in the aqueous extract of human placenta by using ethidium bromide (EtBr) has been described here. It has been demonstrated by thin layer chromatography (TLC) followed by reversed phase HPLC that EtBr binds specifically with the PDRN fraction of the multi-component extract. The binding specificity of EtBr has been verified by the analysis of emission spectra of the extract. A concentration of 0.29 μg/ml EtBr exhibits a linear range of standard CT-DNA from 0.5 - 5 μg/ml of buffer (R2 = 0.992). The same concentration of EtBr shows a linear range of measurements of placenta extract from 5 - 35 μl/ml of buffer (R2 = 0.976). The points of the curve were the average of three sets where maximum variation observed was ±3%. PDRN content of the extract has been estimated based on the resultant fluorescence emission (after background correction) with respect to the standard calibration curve of calf thymus DNA (CT-DNA). Estimation of PDRN in a large number of batches of placenta extract (n = 100) has been done. The statistical analysis of the estimation was found to be significant and the lower and upper levels of PDRN were 158.30 and 239.03 μg/ml of the extract respectively. This easy-to-use method of estimation of PDRN in multi-component biological extract is reported for the first time. This will help in quantitation of PDRNs for other biological extracts.

Share and Cite:

Chakraborty, P.D., Goswami, S., Bera, S. and Mukhopadhyay, I. (2014) Quantitation of Polydeoxyribonucletides (PDRNs) in Human Placental Extract by Fluorescence Spectroscopy Using Ethidium Bromide. American Journal of Analytical Chemistry, 5, 784-795. doi: 10.4236/ajac.2014.512087.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Ramakrishnan, K.M. and Jayaraman, V. (1997) Management of Partial-Thickness Burn Wounds by Amniotic Membrane: A Cost-Effective Treatment in Developing Countries. Burns, 23, S33-S36.
[2] Chakraborty, P.D. and Bhattacharyya, D. (2012) Aqueous Extract of Human Placenta as a Therapeutic Agent in Recent Advances in Research on the Human Placenta. In Tech Publishers, Rijeka, 77-92.
[3] Tonello, G., Daglio, M., Zaccarelli, N., Sottofattori, E., Mazzei, M. and Balbi, A. (1996) Characterization and Quanti- tation of the Active Polynucleotide Fraction (PDRN) from Human Placenta, a Tissue Repair-Stimulating Agent. Journal of Pharmaceutical and Biomedical Analysis, 14, 1555-1560.
[4] Chakraborty, P.D. and Bhattacharyya, D. (2005) Isolation of Fibronectin Type III Like Peptide from Human Placental Extract Used as Wound Healer. Journal of Chromatography B, 818, 67-73.
[5] Biswas, T.K., Auddy, B., Bhattacharyya, N.P., Bhattacharyya, S. and Mukherjee, B. (2001) Wound Healing Activity of Human Placental Extract in Rats. Acta Pharmacologica Sinica, 22, 1113-1116.
[6] Altavilla, D., Bitto, A., Polito, F., Marini, H., Minutoli, L., Di Stefano, V., Irrera, N., Cattarini, G. and Squadrito, F. (2009) Polydeoxyribonucleotide (PDRN): A Safe Approach to Induce Therapeutic Angiogenesis in Peripheral Artery Occlusive Disease and in Diabetic Foot Ulcers. Cardiovascular Hematological Agents in Medicinal Chemistry, 7, 313-321.
[7] Sini, P., Denti, A., Cattarini, G., Daglio, M., Tira, M.E. and Balduini, C. (1999) Effect of Polydeoxyribonucleotides on Human Fibroblasts in Primary Culture. Cell Biochemistry and Function, 17, 107-114.
[8] Guizzardi, S., Galli, C., Govoni, P., Boratto, R., Cattarini, G., Martini, D., Belletti, S. and Scandroglio, R. (2003) Polydeoxyribonu-cleotide (PDRN) Promotes Human Osteoblast Proliferation: A New Proposal for Bone Tissue Repair. Life Sciences, 73, 1973-1983.
[9] Rubegni, P., De Aloe, G., Mazzatenta, C., Cattarini, L. and Fimiani M. (2001) Clinical Evaluation of the Trophic Effect of Polydeoxyribonucleotide (PDRN) in Patients Undergoing Skin Explants. A Pilot Study. Current Medical Research and Opinion, 17, 128-131.
[10] Thellung, S., Florio, T., Maragliano, A., Cattarini, G. and Schettini, G. (1999) Polydeoxyribonucleotides Enhance the Proliferation of Human Skin Fibroblasts: Involvement of A2 Purinergic Receptor Subtypes. Life Sciences, 64, 1661-1674.
[11] Valdatta, L., Thione, A., Mortasino, C., Buoro, M. and Tuinder, S. (2004) Evaluation of the Efficacy of Polydeoxyribonucleotides in the Healing Process of Autologous Skin Graft Donor Sites: A Pilot Study. Current Medical Research and Opinion, 20, 403-404.
[12] Lazzarotto, M., Tomasello, E.M. and Caporossi, A. (2004) Clinical Evaluation of Corneal Epithelialization after Photorefractive Keratectomy in Patients Treated with Poly-deoxyribonucleitide (PDRN) Eye Drops: A Randomized, Double-Blind, Placebo-Controlled Trial. European Journal of Ophthalmology, 14, 284-289.
[13] Datta, P. and Bhattacharyya, D. (2004) Spectroscopic and Chromatographic Evidences of NADPH in Human Placental Extract Used as Wound Healer. Journal of Pharmaceutical and Biomedical Analysis, 34, 1091-1098.
[14] De, D., Chakraborty, P.D. and Bhattacharyya, D. (2009) Analysis of Free and Bound NADPH in Aqueous Extract of Human Placenta Used as Wound Healer. Journal of Chromatography B, 877, 2435-2442.
[15] De, D., Chakraborty, P.D. and Bhattacharyya, D. (2010) Regulation of Trypsin Activity by Peptide Fraction of an Aqueous Extract of Human Placenta Used as Wound Healer. Journal of Cellular Physiology, 226, 2033-2040.
[16] De, D., Chakraborty, P.D., Mitra, J., Sharma, K., Mandal, S., Das, A., Chakrabarti, S. and Bhattacharyya, D. (2013) Ubiquitin-Like Protein from Human Placental Extract Exhibits Collagenase Activity. PLoS ONE, 8, e59585.
[17] Chakraborty, P.D. and Bhattacharyya, D. (2005) In Vitro Growth Inhibition of Microbes by Human Placental Extract. Current Science, 88, 782-786.
[18] Chakraborty, P.D., Bhattacharyya, D., Pal, S. and Ali, N. (2006) In Vitro Induction of Nitric Oxide by Mouse Peritoneal Macrophages Treated with Human Placental Extract. International Immunopharmacology, 6, 100-107.
[19] Nath, S., Bhattacharyya, D. (2007) Cell Adhesion by Aqueous Extract of Human Placenta Used as Wound Healer. Indian Journal of Experimental Biology, 45, 732-738.
[20] Bonasera, V., Alberti, S. and Sacchetti, A. (2007) Protocol for High-Sensitivity/Long Linear-Range Spectrofluorimetric DNA Quantification Using Ethidium Bromide. BioTechniques, 43, 173-176.
[21] Tataurov, A.V., You, Y. and Owczarzy, R. (2008) Predicting Ultra-violet Spectrum of Single Stranded and Double Stranded Deoxyribonucleic Acids. Biophysical Chemistry, 133, 66-70.
[22] Glasel, J. (1995) Validity of Nucleic Acid Purities Monitored by 260/280 Absorbance Ratios. BioTechniques, 18, 62-63.
[23] Bitto, A., Polito, F., Altavilla, D., Minutoli, L., Migliorato, A. and Squadrito, F. (2008) Polydeoxyribonucleotide (PDRN) Restores Blood Flow in an Experimental Model of Peripheral Artery. Journal of Vascular Surgery, 48, 1292-1300.
[24] Datta, P. and Bhattacharyya, D. (2004) Analysis of Fluorescence Excitation-Emission Matrix of Multicomponent Drugs. A Case Study with Human Placental Extract Used as Wound Healer. Journal of Pharmaceutical and Biomedical Analysis, 36, 211-218.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.